speb/financial-data huggingface dataset:
PGEN balance_sheet (quarterly, 2025-06-30) — Land And Improvements: 164000.00
PGEN balance_sheet (quarterly, 2025-06-30) — Leases: 4497000.00
PGEN balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 4223000.00
PGEN balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 4223000.00
PGEN balance_sheet (quarterly, 2025-06-30) — Machinery Furniture Equipment: 2656000.00
PGEN cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: 0.00
PGEN income_statement (quarterly, 2025-06-30) — Net Income: -26642000.00
PGEN income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -26642000.00
PGEN income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -26642000.00
PGEN income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -26642000.00
PGEN income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -26642000.00
PGEN cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -26642000.00
PGEN income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -26642000.00
PGEN income_statement (quarterly, 2025-06-30) — Net Interest Income: 696000.00
PGEN cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: 29408000.00
PGEN income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: 696000.00
PGEN cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: -1839000.00
PGEN balance_sheet (quarterly, 2025-06-30) — Net PPE: 19429000.00
PGEN cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -966000.00
PGEN balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: -55829000.00
PGEN balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 1818000.00
PGEN balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Revenue: 1818000.00
PGEN income_statement (quarterly, 2025-06-30) — Normalized EBITDA: -26562000.00
PGEN income_statement (quarterly, 2025-06-30) — Normalized Income: -27078870.00
PGEN cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: -18977000.00
PGEN cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: -4446000.00
PGEN income_statement (quarterly, 2025-06-30) — Operating Income: -27857000.00
PGEN income_statement (quarterly, 2025-06-30) — Operating Revenue: 822000.00
PGEN balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 297846160.00
PGEN balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 2431000.00
PGEN balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: 11000.00
PGEN income_statement (quarterly, 2025-06-30) — Other Income Expense: 522000.00
PGEN balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 3818000.00
PGEN cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 0.00
PGEN balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 662000.00
PGEN income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: -31000.00
PGEN balance_sheet (quarterly, 2025-06-30) — Other Properties: 21555000.00
PGEN balance_sheet (quarterly, 2025-06-30) — Other Receivables: 244000.00
PGEN balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 45993000.00
PGEN balance_sheet (quarterly, 2025-06-30) — Payables: 3922000.00
PGEN balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 16649000.00
PGEN balance_sheet (quarterly, 2025-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 5201000.00
PGEN balance_sheet (quarterly, 2025-06-30) — Preferred Securities Outside Stock Equity: 30883000.00
PGEN income_statement (quarterly, 2025-06-30) — Pretax Income: -26639000.00
PGEN cash_flow (quarterly, 2025-06-30) — Proceeds From Stock Option Exercised: 73000.00
PGEN balance_sheet (quarterly, 2025-06-30) — Properties: 0.00
PGEN cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: -28467000.00
PGEN cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -966000.00
PGEN balance_sheet (quarterly, 2025-06-30) — Receivables: 571000.00
PGEN income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 1092000.00
PGEN income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 630000.00
PGEN cash_flow (quarterly, 2025-06-30) — Repurchase Of Capital Stock: 0.00
PGEN income_statement (quarterly, 2025-06-30) — Research And Development: 11488000.00
PGEN balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -2171501000.00
PGEN cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 57875000.00
PGEN income_statement (quarterly, 2025-06-30) — Selling General And Administration: 16133000.00
PGEN balance_sheet (quarterly, 2025-06-30) — Share Issued: 297846160.00
PGEN income_statement (quarterly, 2025-06-30) — Special Income Charges: -3907000.00
PGEN cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 1638000.00
PGEN balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: -36779000.00
PGEN balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: -55829000.00
PGEN income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 116130.00
PGEN income_statement (quarterly, 2025-06-30) — Tax Provision: 3000.00
PGEN income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.21
PGEN balance_sheet (quarterly, 2025-06-30) — Total Assets: 101896000.00
PGEN balance_sheet (quarterly, 2025-06-30) — Total Capitalization: -36779000.00
PGEN balance_sheet (quarterly, 2025-06-30) — Total Debt: 5153000.00
PGEN balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: -36779000.00
PGEN income_statement (quarterly, 2025-06-30) — Total Expenses: 28713000.00
PGEN balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 138675000.00
PGEN balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 39141000.00
PGEN balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 115482000.00
PGEN income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: -31764000.00
PGEN income_statement (quarterly, 2025-06-30) — Total Unusual Items: 553000.00
PGEN income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: 553000.00
PGEN balance_sheet (quarterly, 2025-06-30) — Working Capital: 39562000.00
PGEN income_statement (quarterly, 2025-09-30) — +Operating Expense: 36368000.00
PGEN income_statement (quarterly, 2025-09-30) — +Total Revenue: 2922000.00
PGEN balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 6262000.00
PGEN balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 580000.00
PGEN balance_sheet (quarterly, 2025-09-30) — Accumulated Depreciation: -23006000.00
PGEN balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 2359689000.00
PGEN balance_sheet (quarterly, 2025-09-30) — Allowance For Doubtful Accounts Receivable: 0.00
PGEN cash_flow (quarterly, 2025-09-30) — Amortization Cash Flow: 318000.00
PGEN cash_flow (quarterly, 2025-09-30) — Amortization Of Intangibles: 318000.00
PGEN cash_flow (quarterly, 2025-09-30) — Amortization Of Securities: -318000.00
PGEN cash_flow (quarterly, 2025-09-30) — Asset Impairment Charge: 0.00
PGEN balance_sheet (quarterly, 2025-09-30) — Available For Sale Securities: 2508000.00
PGEN income_statement (quarterly, 2025-09-30) — Basic Average Shares: 307170490.00
PGEN income_statement (quarterly, 2025-09-30) — Basic EPS: -1.06
PGEN cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 13760000.00
PGEN balance_sheet (quarterly, 2025-09-30) — Buildings And Improvements: 2629000.00
PGEN cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -389000.00
PGEN balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 5302000.00
PGEN balance_sheet (quarterly, 2025-09-30) — Capital Stock: 0.00
PGEN balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 14322000.00
PGEN balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 121135000.00
PGEN cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: 93007000.00
PGEN cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -63386000.00
PGEN cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: -29069000.00
PGEN cash_flow (quarterly, 2025-09-30) — Change In Account Payable: 1548000.00
PGEN cash_flow (quarterly, 2025-09-30) — Change In Accrued Expense: 1232000.00
PGEN cash_flow (quarterly, 2025-09-30) — Change In Other Current Assets: -167000.00
PGEN cash_flow (quarterly, 2025-09-30) — Change In Other Current Liabilities: 257000.00
PGEN cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: 3310000.00
PGEN cash_flow (quarterly, 2025-09-30) — Change In Payable: 1548000.00
PGEN cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 2780000.00
PGEN cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: -1872000.00
PGEN cash_flow (quarterly, 2025-09-30) — Change In Receivables: -532000.00
PGEN cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 828000.00
PGEN cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: -253000.00
PGEN cash_flow (quarterly, 2025-09-30) — Changes In Cash: 552000.00
PGEN balance_sheet (quarterly, 2025-09-30) — Common Stock: 0.00
PGEN balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 41868000.00
PGEN cash_flow (quarterly, 2025-09-30) — Common Stock Payments: -1304000.00
PGEN balance_sheet (quarterly, 2025-09-30) — Construction In Progress: 263000.00
PGEN income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 1035000.00
PGEN balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 14037000.00
PGEN balance_sheet (quarterly, 2025-09-30) — Current Assets: 129597000.00
PGEN balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 1123000.00
PGEN balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 1123000.00
PGEN balance_sheet (quarterly, 2025-09-30) — Current Deferred Liabilities: 480000.00
PGEN balance_sheet (quarterly, 2025-09-30) — Current Deferred Revenue: 480000.00
PGEN balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 32069000.00
PGEN cash_flow (quarterly, 2025-09-30) — Deferred Income Tax: 0.00
PGEN cash_flow (quarterly, 2025-09-30) — Deferred Tax: 0.00
PGEN cash_flow (quarterly, 2025-09-30) — Depreciation: 485000.00
PGEN cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 803000.00
PGEN cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 803000.00
PGEN balance_sheet (quarterly, 2025-09-30) — Derivative Product Liabilities: 0.00
PGEN income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 307170490.00
PGEN income_statement (quarterly, 2025-09-30) — Diluted EPS: -1.06
PGEN income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -325344000.00
PGEN income_statement (quarterly, 2025-09-30) — EBIT: -145442000.00
PGEN income_statement (quarterly, 2025-09-30) — EBITDA: -144639000.00
PGEN cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: 10000.00
PGEN cash_flow (quarterly, 2025-09-30) — End Cash Position: 14322000.00
PGEN cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 93007000.00
PGEN cash_flow (quarterly, 2025-09-30) — Free Cash Flow: -29458000.00
PGEN cash_flow (quarterly, 2025-09-30) — Gain Loss On Investment Securities: 111502000.00
PGEN income_statement (quarterly, 2025-09-30) — Gain On Sale Of Security: -111502000.00
PGEN balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: 24000.00
PGEN balance_sheet (quarterly, 2025-09-30) — Goodwill: 15232000.00
PGEN balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 18732000.00
PGEN balance_sheet (quarterly, 2025-09-30) — Gross Accounts Receivable: 580000.00
PGEN balance_sheet (quarterly, 2025-09-30) — Gross PPE: 42601000.00
PGEN income_statement (quarterly, 2025-09-30) — Gross Profit: 1887000.00
PGEN income_statement (quarterly, 2025-09-30) — Impairment Of Capital Assets: 0.00
PGEN cash_flow (quarterly, 2025-09-30) — Income Tax Paid Supplemental Data: 0.00
PGEN income_statement (quarterly, 2025-09-30) — Interest Expense: 902000.00
PGEN income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 902000.00
PGEN income_statement (quarterly, 2025-09-30) — Interest Income: 534000.00
PGEN income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 534000.00
PGEN cash_flow (quarterly, 2025-09-30) — Interest Paid Supplemental Data: 830000.00
PGEN balance_sheet (quarterly, 2025-09-30) — Inventory: 3059000.00
PGEN balance_sheet (quarterly, 2025-09-30) — Invested Capital: 134758000.00
PGEN cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -63386000.00
PGEN balance_sheet (quarterly, 2025-09-30) — Investmentin Financial Assets: 2508000.00
PGEN balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 2508000.00
PGEN balance_sheet (quarterly, 2025-09-30) — Land And Improvements: 164000.00
PGEN balance_sheet (quarterly, 2025-09-30) — Leases: 11903000.00
PGEN balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 4179000.00
PGEN balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 92890000.00
PGEN balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 97069000.00
PGEN balance_sheet (quarterly, 2025-09-30) — Machinery Furniture Equipment: 3506000.00
PGEN cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: -1304000.00
PGEN balance_sheet (quarterly, 2025-09-30) — Net Debt: 78568000.00
PGEN income_statement (quarterly, 2025-09-30) — Net Income: -146344000.00
PGEN income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -325344000.00
PGEN income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -146344000.00
PGEN income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -146344000.00
PGEN income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -146344000.00
PGEN cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -146344000.00
PGEN income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -146344000.00
PGEN income_statement (quarterly, 2025-09-30) — Net Interest Income: -368000.00
PGEN cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: -62997000.00
PGEN income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -368000.00
PGEN cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: 0.00
PGEN balance_sheet (quarterly, 2025-09-30) — Net PPE: 19595000.00
PGEN cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -389000.00
PGEN balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 23136000.00
PGEN balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 95000.00
PGEN balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Revenue: 95000.00
PGEN income_statement (quarterly, 2025-09-30) — Normalized EBITDA: -33137000.00
PGEN income_statement (quarterly, 2025-09-30) — Normalized Income: -34842000.00
PGEN cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: -29069000.00
PGEN cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: 111502000.00
PGEN income_statement (quarterly, 2025-09-30) — Operating Income: -34481000.00
PGEN income_statement (quarterly, 2025-09-30) — Operating Revenue: 2922000.00
PGEN balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 353810556.00
PGEN balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 4303000.00
PGEN balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: 24000.00
PGEN income_statement (quarterly, 2025-09-30) — Other Income Expense: -111495000.00
PGEN balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 3500000.00
PGEN cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 72000.00
PGEN balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 832000.00
PGEN balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 163000.00
PGEN income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 7000.00
PGEN balance_sheet (quarterly, 2025-09-30) — Other Properties: 24136000.00
PGEN balance_sheet (quarterly, 2025-09-30) — Other Receivables: 520000.00
PGEN balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 106813000.00
PGEN balance_sheet (quarterly, 2025-09-30) — Payables: 6262000.00
PGEN balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 20299000.00
PGEN balance_sheet (quarterly, 2025-09-30) — Pensionand Other Post Retirement Benefit Plans Current: 10167000.00
PGEN balance_sheet (quarterly, 2025-09-30) — Preferred Securities Outside Stock Equity: 0.00
PGEN income_statement (quarterly, 2025-09-30) — Preferred Stock Dividends: 179000000.00
PGEN income_statement (quarterly, 2025-09-30) — Pretax Income: -146344000.00
PGEN cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: 839000.00
PGEN balance_sheet (quarterly, 2025-09-30) — Properties: 0.00
PGEN cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: -145271000.00
PGEN cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -389000.00
PGEN balance_sheet (quarterly, 2025-09-30) — Receivables: 1100000.00
PGEN income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 1035000.00
PGEN income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 803000.00
PGEN cash_flow (quarterly, 2025-09-30) — Repurchase Of Capital Stock: -1304000.00
PGEN income_statement (quarterly, 2025-09-30) — Research And Development: 12377000.00
PGEN balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -2317845000.00
PGEN cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 82274000.00
PGEN income_statement (quarterly, 2025-09-30) — Selling General And Administration: 23991000.00
PGEN balance_sheet (quarterly, 2025-09-30) — Share Issued: 353810556.00
PGEN income_statement (quarterly, 2025-09-30) — Special Income Charges: 0.00
PGEN cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 4388000.00
PGEN balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 41868000.00
PGEN balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 23136000.00
PGEN income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
PGEN income_statement (quarterly, 2025-09-30) — Tax Provision: 0.00
PGEN income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.00
PGEN balance_sheet (quarterly, 2025-09-30) — Total Assets: 171264000.00
PGEN balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 134758000.00
PGEN balance_sheet (quarterly, 2025-09-30) — Total Debt: 98192000.00
PGEN balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 41868000.00
PGEN income_statement (quarterly, 2025-09-30) — Total Expenses: 37403000.00
PGEN balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 129396000.00
PGEN balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 41667000.00
PGEN balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 97327000.00
PGEN income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: -34481000.00
PGEN income_statement (quarterly, 2025-09-30) — Total Unusual Items: -111502000.00
PGEN income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: -111502000.00
PGEN balance_sheet (quarterly, 2025-09-30) — Working Capital: 97528000.00
PGEN income_statement (annual, 2025-12-31) — +Operating Expense: 111461000.00
PGEN income_statement (quarterly, 2025-12-31) — +Operating Expense: 24635000.00
PGEN income_statement (annual, 2025-12-31) — +Total Revenue: 9684000.00
PGEN income_statement (quarterly, 2025-12-31) — +Total Revenue: 4565000.00
PGEN balance_sheet (annual, 2025-12-31) — Accounts Payable: 11985000.00
PGEN balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 11985000.00
PGEN balance_sheet (annual, 2025-12-31) — Accounts Receivable: 3916000.00
PGEN balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 3916000.00
PGEN balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -23823000.00
PGEN balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -23823000.00
PGEN balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 2362252000.00
PGEN balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 2362252000.00
PGEN balance_sheet (annual, 2025-12-31) — Allowance For Doubtful Accounts Receivable: 0.00
PGEN balance_sheet (quarterly, 2025-12-31) — Allowance For Doubtful Accounts Receivable: 0.00
PGEN cash_flow (annual, 2025-12-31) — Amortization Cash Flow: 1273000.00
PGEN cash_flow (quarterly, 2025-12-31) — Amortization Cash Flow: 318000.00
PGEN cash_flow (annual, 2025-12-31) — Amortization Of Intangibles: 1273000.00
PGEN cash_flow (quarterly, 2025-12-31) — Amortization Of Intangibles: 318000.00
PGEN cash_flow (annual, 2025-12-31) — Amortization Of Securities: -2205000.00
PGEN cash_flow (quarterly, 2025-12-31) — Amortization Of Securities: -713000.00
PGEN cash_flow (annual, 2025-12-31) — Asset Impairment Charge: 3907000.00
PGEN cash_flow (quarterly, 2025-12-31) — Asset Impairment Charge: 0.00
PGEN balance_sheet (annual, 2025-12-31) — Available For Sale Securities: 2511000.00
PGEN balance_sheet (quarterly, 2025-12-31) — Available For Sale Securities: 2511000.00
PGEN income_statement (annual, 2025-12-31) — Basic Average Shares: 312980562.00
PGEN income_statement (annual, 2025-12-31) — Basic EPS: -1.37
PGEN cash_flow (annual, 2025-12-31) — Beginning Cash Position: 29517000.00
PGEN cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 14322000.00
PGEN balance_sheet (annual, 2025-12-31) — Buildings And Improvements: 2629000.00
PGEN balance_sheet (quarterly, 2025-12-31) — Buildings And Improvements: 2629000.00
PGEN cash_flow (annual, 2025-12-31) — Capital Expenditure: -1995000.00
PGEN cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -18000.00
PGEN balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 5116000.00
PGEN balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 5116000.00
PGEN balance_sheet (annual, 2025-12-31) — Capital Stock: 0.00
PGEN balance_sheet (quarterly, 2025-12-31) — Capital Stock: 0.00
PGEN balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 30234000.00
PGEN balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 30234000.00
PGEN balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 97858000.00
PGEN balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 97858000.00
PGEN cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 90048000.00
PGEN cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -514000.00
PGEN cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -1535000.00
PGEN cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: 39866000.00
PGEN cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: -87831000.00
PGEN cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: -23460000.00
PGEN cash_flow (annual, 2025-12-31) — Change In Account Payable: 8768000.00
PGEN cash_flow (quarterly, 2025-12-31) — Change In Account Payable: 6536000.00
PGEN cash_flow (annual, 2025-12-31) — Change In Accrued Expense: 6869000.00
PGEN cash_flow (quarterly, 2025-12-31) — Change In Accrued Expense: 259000.00
PGEN cash_flow (annual, 2025-12-31) — Change In Inventory: -9209000.00
PGEN cash_flow (quarterly, 2025-12-31) — Change In Inventory: -6261000.00
PGEN cash_flow (annual, 2025-12-31) — Change In Other Current Assets: -556000.00
PGEN cash_flow (quarterly, 2025-12-31) — Change In Other Current Assets: -174000.00
PGEN cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: 125000.00
PGEN cash_flow (quarterly, 2025-12-31) — Change In Other Current Liabilities: -33000.00
PGEN cash_flow (annual, 2025-12-31) — Change In Other Working Capital: 4656000.00
PGEN cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: -25000.00
PGEN cash_flow (annual, 2025-12-31) — Change In Payable: 8768000.00
PGEN cash_flow (quarterly, 2025-12-31) — Change In Payable: 6536000.00
PGEN cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 15637000.00
PGEN cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 6795000.00
PGEN cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: -93000.00
PGEN cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: 869000.00
PGEN cash_flow (annual, 2025-12-31) — Change In Receivables: -3199000.00
PGEN cash_flow (quarterly, 2025-12-31) — Change In Receivables: -3262000.00
PGEN cash_flow (annual, 2025-12-31) — Change In Working Capital: 7361000.00
PGEN cash_flow (quarterly, 2025-12-31) — Change In Working Capital: -2091000.00
PGEN cash_flow (annual, 2025-12-31) — Changes In Account Receivables: -2990000.00
PGEN cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: -3336000.00
PGEN cash_flow (annual, 2025-12-31) — Changes In Cash: 682000.00
PGEN cash_flow (quarterly, 2025-12-31) — Changes In Cash: 15892000.00
PGEN balance_sheet (annual, 2025-12-31) — Common Stock: 0.00
PGEN balance_sheet (quarterly, 2025-12-31) — Common Stock: 0.00
PGEN balance_sheet (annual, 2025-12-31) — Common Stock Equity: 20911000.00
PGEN balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 20911000.00
PGEN cash_flow (annual, 2025-12-31) — Common Stock Payments: -1659000.00
PGEN cash_flow (quarterly, 2025-12-31) — Common Stock Payments: 0.00
PGEN balance_sheet (annual, 2025-12-31) — Construction In Progress: 278000.00
PGEN balance_sheet (quarterly, 2025-12-31) — Construction In Progress: 278000.00
PGEN income_statement (annual, 2025-12-31) — Cost Of Revenue: 4823000.00
PGEN income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 1596000.00
PGEN balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 13469000.00
PGEN balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 13469000.00
PGEN balance_sheet (annual, 2025-12-31) — Current Assets: 115235000.00
PGEN balance_sheet (quarterly, 2025-12-31) — Current Assets: 115235000.00
PGEN balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 1136000.00
PGEN balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 1136000.00
PGEN balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 1136000.00
PGEN balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 1136000.00
PGEN balance_sheet (annual, 2025-12-31) — Current Deferred Liabilities: 517000.00
PGEN balance_sheet (quarterly, 2025-12-31) — Current Deferred Liabilities: 517000.00
PGEN balance_sheet (annual, 2025-12-31) — Current Deferred Revenue: 517000.00
PGEN balance_sheet (quarterly, 2025-12-31) — Current Deferred Revenue: 517000.00
PGEN balance_sheet (annual, 2025-12-31) — Current Liabilities: 37306000.00
PGEN balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 37306000.00
PGEN cash_flow (annual, 2025-12-31) — Deferred Income Tax: 0.00
PGEN cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: 0.00
PGEN cash_flow (annual, 2025-12-31) — Deferred Tax: 0.00
PGEN cash_flow (quarterly, 2025-12-31) — Deferred Tax: 0.00
PGEN cash_flow (annual, 2025-12-31) — Depreciation: 1926000.00
PGEN cash_flow (quarterly, 2025-12-31) — Depreciation: 819000.00
PGEN cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 3199000.00
PGEN cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 1137000.00
PGEN cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 3199000.00
PGEN cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 1137000.00
PGEN balance_sheet (annual, 2025-12-31) — Derivative Product Liabilities: 0.00
PGEN balance_sheet (quarterly, 2025-12-31) — Derivative Product Liabilities: 0.00
PGEN income_statement (annual, 2025-12-31) — Diluted Average Shares: 312980562.00
PGEN income_statement (annual, 2025-12-31) — Diluted EPS: -1.37
PGEN income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: -429642000.00
PGEN income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -23503000.00
PGEN income_statement (annual, 2025-12-31) — EBIT: -246772000.00
PGEN income_statement (quarterly, 2025-12-31) — EBIT: -20539000.00
PGEN income_statement (annual, 2025-12-31) — EBITDA: -243573000.00
PGEN income_statement (quarterly, 2025-12-31) — EBITDA: -19402000.00
PGEN cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: 35000.00
PGEN cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: 20000.00
PGEN cash_flow (annual, 2025-12-31) — End Cash Position: 30234000.00
PGEN cash_flow (quarterly, 2025-12-31) — End Cash Position: 30234000.00
PGEN cash_flow (annual, 2025-12-31) — Financing Cash Flow: 90048000.00
PGEN cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -514000.00
PGEN balance_sheet (annual, 2025-12-31) — Finished Goods: 172000.00
PGEN balance_sheet (quarterly, 2025-12-31) — Finished Goods: 172000.00
PGEN cash_flow (annual, 2025-12-31) — Free Cash Flow: -89826000.00
PGEN cash_flow (quarterly, 2025-12-31) — Free Cash Flow: -23478000.00
PGEN cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: 139523000.00
PGEN cash_flow (quarterly, 2025-12-31) — Gain Loss On Investment Securities: 0.00
PGEN income_statement (annual, 2025-12-31) — Gain On Sale Of Security: -139523000.00
PGEN income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: 0.00
PGEN balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 7000.00
PGEN balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 7000.00
PGEN balance_sheet (annual, 2025-12-31) — Goodwill: 15232000.00
PGEN balance_sheet (quarterly, 2025-12-31) — Goodwill: 15232000.00
PGEN balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 18414000.00
PGEN balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 18414000.00
PGEN balance_sheet (annual, 2025-12-31) — Gross Accounts Receivable: 3916000.00
PGEN balance_sheet (quarterly, 2025-12-31) — Gross Accounts Receivable: 3916000.00
PGEN balance_sheet (annual, 2025-12-31) — Gross PPE: 42186000.00
PGEN balance_sheet (quarterly, 2025-12-31) — Gross PPE: 42186000.00
PGEN income_statement (annual, 2025-12-31) — Gross Profit: 4861000.00
PGEN income_statement (quarterly, 2025-12-31) — Gross Profit: 2969000.00
PGEN income_statement (annual, 2025-12-31) — Impairment Of Capital Assets: 3907000.00
PGEN income_statement (quarterly, 2025-12-31) — Impairment Of Capital Assets: 0.00
PGEN cash_flow (annual, 2025-12-31) — Income Tax Paid Supplemental Data: 3000.00
PGEN cash_flow (quarterly, 2025-12-31) — Income Tax Paid Supplemental Data: 0.00
PGEN income_statement (annual, 2025-12-31) — Interest Expense: 3867000.00
PGEN income_statement (quarterly, 2025-12-31) — Interest Expense: 2964000.00
PGEN income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 3867000.00
PGEN income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 2964000.00
PGEN income_statement (annual, 2025-12-31) — Interest Income: 3215000.00
PGEN income_statement (quarterly, 2025-12-31) — Interest Income: 1067000.00
PGEN income_statement (annual, 2025-12-31) — Interest Income Non Operating: 3215000.00
PGEN income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 1067000.00
PGEN cash_flow (annual, 2025-12-31) — Interest Paid Supplemental Data: 3510000.00
PGEN cash_flow (quarterly, 2025-12-31) — Interest Paid Supplemental Data: 2680000.00
PGEN balance_sheet (annual, 2025-12-31) — Inventory: 9581000.00
PGEN balance_sheet (quarterly, 2025-12-31) — Inventory: 9581000.00
PGEN balance_sheet (annual, 2025-12-31) — Invested Capital: 114085000.00
PGEN balance_sheet (quarterly, 2025-12-31) — Invested Capital: 114085000.00
PGEN cash_flow (annual, 2025-12-31) — Investing Cash Flow: -1535000.00
PGEN cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: 39866000.00
PGEN balance_sheet (annual, 2025-12-31) — Investmentin Financial Assets: 2511000.00
PGEN balance_sheet (quarterly, 2025-12-31) — Investmentin Financial Assets: 2511000.00
PGEN balance_sheet (annual, 2025-12-31) — Investments And Advances: 2511000.00
PGEN balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 2511000.00
PGEN cash_flow (annual, 2025-12-31) — Issuance Of Debt: 92818000.00
PGEN cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: -654000.00
PGEN balance_sheet (annual, 2025-12-31) — Land And Improvements: 164000.00
PGEN balance_sheet (quarterly, 2025-12-31) — Land And Improvements: 164000.00
PGEN balance_sheet (annual, 2025-12-31) — Leases: 11934000.00
PGEN balance_sheet (quarterly, 2025-12-31) — Leases: 11934000.00
PGEN balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 3980000.00
PGEN balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 3980000.00
PGEN balance_sheet (annual, 2025-12-31) — Long Term Debt: 93174000.00
PGEN balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 93174000.00
PGEN balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 97154000.00
PGEN balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 97154000.00
PGEN cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 92818000.00
PGEN cash_flow (quarterly, 2025-12-31) — Long Term Debt Issuance: -654000.00
PGEN cash_flow (annual, 2025-12-31) — Long Term Debt Payments: 0.00
PGEN balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 3058000.00
PGEN balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 3058000.00
PGEN cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: -1659000.00
PGEN cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: 0.00
PGEN balance_sheet (annual, 2025-12-31) — Net Debt: 62940000.00
PGEN balance_sheet (quarterly, 2025-12-31) — Net Debt: 62940000.00
PGEN cash_flow (annual, 2025-12-31) — Net Foreign Currency Exchange Gain Loss: 0.00
PGEN cash_flow (quarterly, 2025-12-31) — Net Foreign Currency Exchange Gain Loss: 0.00
PGEN income_statement (annual, 2025-12-31) — Net Income: -250642000.00
PGEN income_statement (quarterly, 2025-12-31) — Net Income: -23503000.00
PGEN income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -429642000.00
PGEN income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -23503000.00
PGEN income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -250642000.00
PGEN income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -23503000.00
PGEN income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -250642000.00
PGEN income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -23503000.00
PGEN income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -250642000.00
PGEN income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -23503000.00
PGEN cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: -250642000.00
PGEN cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: -23503000.00
PGEN income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -250642000.00
PGEN income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -23503000.00
PGEN income_statement (annual, 2025-12-31) — Net Interest Income: -652000.00
PGEN income_statement (quarterly, 2025-12-31) — Net Interest Income: -1897000.00
PGEN cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: 460000.00
PGEN cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: 39884000.00
PGEN cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: 92818000.00
PGEN cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: -654000.00
PGEN cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: 92818000.00
PGEN cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: -654000.00
PGEN income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -652000.00
PGEN income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -1897000.00
PGEN cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -1776000.00
PGEN cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: 537000.00
PGEN balance_sheet (annual, 2025-12-31) — Net PPE: 18363000.00
PGEN balance_sheet (quarterly, 2025-12-31) — Net PPE: 18363000.00
PGEN cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -1995000.00
PGEN cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -18000.00
PGEN cash_flow (annual, 2025-12-31) — Net Preferred Stock Issuance: -537000.00
PGEN balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 2497000.00
PGEN balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 2497000.00
PGEN balance_sheet (annual, 2025-12-31) — Non Current Deferred Liabilities: 0.00
PGEN balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 0.00
PGEN balance_sheet (annual, 2025-12-31) — Non Current Deferred Revenue: 0.00
PGEN balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Revenue: 0.00
PGEN income_statement (annual, 2025-12-31) — Normalized EBITDA: -100143000.00
PGEN income_statement (quarterly, 2025-12-31) — Normalized EBITDA: -19402000.00
PGEN income_statement (annual, 2025-12-31) — Normalized Income: -107212000.00
PGEN income_statement (quarterly, 2025-12-31) — Normalized Income: -23503000.00
PGEN cash_flow (annual, 2025-12-31) — Operating Cash Flow: -87831000.00
PGEN cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: -23460000.00
PGEN cash_flow (annual, 2025-12-31) — Operating Gains Losses: 139537000.00
PGEN cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: 0.00
PGEN income_statement (annual, 2025-12-31) — Operating Income: -106600000.00
PGEN income_statement (quarterly, 2025-12-31) — Operating Income: -21666000.00
PGEN income_statement (annual, 2025-12-31) — Operating Revenue: 9684000.00
PGEN income_statement (quarterly, 2025-12-31) — Operating Revenue: 4622000.00
PGEN balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 353910926.00
PGEN balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 353910926.00
PGEN balance_sheet (annual, 2025-12-31) — Other Current Assets: 3434000.00
PGEN balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 3434000.00
PGEN balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: 7000.00
PGEN balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: 7000.00
PGEN income_statement (annual, 2025-12-31) — Other Income Expense: -143387000.00
PGEN income_statement (quarterly, 2025-12-31) — Other Income Expense: 60000.00
PGEN balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 3182000.00
PGEN balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 3182000.00
PGEN cash_flow (annual, 2025-12-31) — Other Non Cash Items: 146000.00
PGEN cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: -453000.00
PGEN balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 982000.00
PGEN balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 982000.00
PGEN balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 134000.00
PGEN balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 134000.00
PGEN income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: 43000.00
PGEN income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 60000.00
PGEN balance_sheet (annual, 2025-12-31) — Other Properties: 24123000.00
PGEN balance_sheet (quarterly, 2025-12-31) — Other Properties: 24123000.00
PGEN balance_sheet (annual, 2025-12-31) — Other Receivables: 446000.00
PGEN balance_sheet (quarterly, 2025-12-31) — Other Receivables: 446000.00
PGEN balance_sheet (annual, 2025-12-31) — Other Short Term Investments: 67624000.00
PGEN balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 67624000.00
PGEN balance_sheet (annual, 2025-12-31) — Payables: 11985000.00
PGEN balance_sheet (quarterly, 2025-12-31) — Payables: 11985000.00
PGEN balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 25454000.00
PGEN balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 25454000.00
PGEN balance_sheet (annual, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 10199000.00
PGEN balance_sheet (quarterly, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 10199000.00
PGEN balance_sheet (annual, 2025-12-31) — Preferred Securities Outside Stock Equity: 0.00
PGEN balance_sheet (quarterly, 2025-12-31) — Preferred Securities Outside Stock Equity: 0.00
PGEN income_statement (annual, 2025-12-31) — Preferred Stock Dividends: 179000000.00
PGEN income_statement (quarterly, 2025-12-31) — Preferred Stock Dividends: 0.00
PGEN cash_flow (annual, 2025-12-31) — Preferred Stock Payments: -537000.00
PGEN income_statement (annual, 2025-12-31) — Pretax Income: -250639000.00
PGEN income_statement (quarterly, 2025-12-31) — Pretax Income: -23503000.00
PGEN cash_flow (annual, 2025-12-31) — Proceeds From Stock Option Exercised: 1202000.00
PGEN cash_flow (quarterly, 2025-12-31) — Proceeds From Stock Option Exercised: 140000.00
PGEN balance_sheet (annual, 2025-12-31) — Properties: 0.00
PGEN balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
PGEN cash_flow (annual, 2025-12-31) — Purchase Of Investment: -208006000.00
PGEN cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: -23860000.00
PGEN cash_flow (annual, 2025-12-31) — Purchase Of PPE: -1995000.00
PGEN cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -18000.00
PGEN balance_sheet (annual, 2025-12-31) — Raw Materials: 144000.00
PGEN balance_sheet (quarterly, 2025-12-31) — Raw Materials: 144000.00
PGEN balance_sheet (annual, 2025-12-31) — Receivables: 4362000.00
PGEN balance_sheet (quarterly, 2025-12-31) — Receivables: 4362000.00
PGEN income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 4823000.00
PGEN income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 1596000.00
PGEN income_statement (annual, 2025-12-31) — Reconciled Depreciation: 3199000.00
PGEN income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 1137000.00
PGEN cash_flow (annual, 2025-12-31) — Repayment Of Debt: 0.00
PGEN cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: -2196000.00
PGEN cash_flow (quarterly, 2025-12-31) — Repurchase Of Capital Stock: -537000.00
PGEN income_statement (annual, 2025-12-31) — Research And Development: 41333000.00
PGEN income_statement (quarterly, 2025-12-31) — Research And Development: 6990000.00
PGEN balance_sheet (annual, 2025-12-31) — Retained Earnings: -2341348000.00
PGEN balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -2341348000.00
PGEN cash_flow (annual, 2025-12-31) — Sale Of Investment: 208466000.00
PGEN cash_flow (quarterly, 2025-12-31) — Sale Of Investment: 63744000.00
PGEN income_statement (annual, 2025-12-31) — Selling General And Administration: 70128000.00
PGEN income_statement (quarterly, 2025-12-31) — Selling General And Administration: 17645000.00
PGEN balance_sheet (annual, 2025-12-31) — Share Issued: 353910926.00
PGEN balance_sheet (quarterly, 2025-12-31) — Share Issued: 353910926.00
PGEN income_statement (annual, 2025-12-31) — Special Income Charges: -3907000.00
PGEN income_statement (quarterly, 2025-12-31) — Special Income Charges: 0.00
PGEN cash_flow (annual, 2025-12-31) — Stock Based Compensation: 10866000.00
PGEN cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 2163000.00
PGEN balance_sheet (annual, 2025-12-31) — Stockholders Equity: 20911000.00
PGEN balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 20911000.00
PGEN balance_sheet (annual, 2025-12-31) — Tangible Book Value: 2497000.00
PGEN balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 2497000.00
PGEN income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
PGEN income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
PGEN income_statement (annual, 2025-12-31) — Tax Provision: 3000.00
PGEN income_statement (quarterly, 2025-12-31) — Tax Provision: 0.00
PGEN income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.00
PGEN income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.00
PGEN balance_sheet (annual, 2025-12-31) — Total Assets: 155505000.00
PGEN balance_sheet (quarterly, 2025-12-31) — Total Assets: 155505000.00
PGEN balance_sheet (annual, 2025-12-31) — Total Capitalization: 114085000.00
PGEN balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 114085000.00
PGEN balance_sheet (annual, 2025-12-31) — Total Debt: 98290000.00
PGEN balance_sheet (quarterly, 2025-12-31) — Total Debt: 98290000.00
PGEN balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 20911000.00
PGEN balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 20911000.00
PGEN income_statement (annual, 2025-12-31) — Total Expenses: 116284000.00
PGEN income_statement (quarterly, 2025-12-31) — Total Expenses: 26231000.00
PGEN balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 134594000.00
PGEN balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 134594000.00
PGEN balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 40270000.00
PGEN balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 40270000.00
PGEN balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 97288000.00
PGEN balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 97288000.00
PGEN income_statement (annual, 2025-12-31) — Total Operating Income As Reported: -110507000.00
PGEN income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: -21666000.00
PGEN income_statement (annual, 2025-12-31) — Total Unusual Items: -143430000.00
PGEN income_statement (quarterly, 2025-12-31) — Total Unusual Items: 0.00
PGEN income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: -143430000.00
PGEN income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: 0.00
PGEN balance_sheet (annual, 2025-12-31) — Work In Process: 9265000.00
PGEN balance_sheet (quarterly, 2025-12-31) — Work In Process: 9265000.00
PGEN balance_sheet (annual, 2025-12-31) — Working Capital: 77929000.00
PGEN balance_sheet (quarterly, 2025-12-31) — Working Capital: 77929000.00
PGEN income_statement (quarterly, 2026-03-31) — +Operating Expense: 26687000.00
PGEN income_statement (quarterly, 2026-03-31) — +Total Revenue: 3108556.15
PGEN balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 2589000.00
PGEN balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 26403000.00
PGEN balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -24602000.00
PGEN balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 2369529000.00
PGEN balance_sheet (quarterly, 2026-03-31) — Allowance For Doubtful Accounts Receivable: 0.00
PGEN cash_flow (quarterly, 2026-03-31) — Amortization Cash Flow: 318000.00
PGEN cash_flow (quarterly, 2026-03-31) — Amortization Of Intangibles: 318000.00
PGEN cash_flow (quarterly, 2026-03-31) — Amortization Of Securities: -369000.00
PGEN balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 489000.00
PGEN income_statement (quarterly, 2026-03-31) — Basic Average Shares: 354291007.00
PGEN income_statement (quarterly, 2026-03-31) — Basic EPS: -0.02
PGEN cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 30234000.00
PGEN balance_sheet (quarterly, 2026-03-31) — Buildings And Improvements: 2629000.00
PGEN cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -258000.00
PGEN balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 4731000.00
PGEN balance_sheet (quarterly, 2026-03-31) — Capital Stock: 0.00
PGEN balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 7480000.00
PGEN balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 56246000.00
PGEN cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: 109000.00
PGEN cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: 20967000.00